Structures by: Hannioui A.
Total: 7
Ethyl 10α-hydroxy-4,9-dimethyl-14-oxo-3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecane-13-spiro-5-pyrazole-3'-carboxylate
C25H29ClN2O7
IUCrData (2020) 5, 7 x200945
a=9.2324(3)Å b=11.1656(4)Å c=23.3497(8)Å
α=90° β=90° γ=90°
9α-Hydroxy-4,8-dimethyl-3-phenyl-3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one-12-spiro-5'-isoxazole monohydrate
C22H25NO5,H2O
IUCrData (2019) 4, 10 x191408
a=9.8947(4)Å b=10.6554(4)Å c=19.0286(8)Å
α=90° β=90° γ=90°
2-(4-Methylbenzylidene)malononitrile
C11H8N2
Acta Crystallographica Section E (2014) 70, 12 o1263
a=7.0043(5)Å b=7.5270(5)Å c=9.5396(6)Å
α=106.757(4)° β=96.592(4)° γ=105.204(4)°
<i>N</i>-(3-Chloro-4-ethoxy-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C17H18ClN3O4S
Acta Crystallographica Section E (2014) 70, 6 o679
a=8.5296(9)Å b=8.6165(9)Å c=12.9821(14)Å
α=91.810(6)° β=102.566(5)° γ=100.514(5)°
<i>N</i>-[7-Ethoxy-2-(prop-2-en-1-yl)-2<i>H</i>-indazol-6-yl]-4- methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3211
a=10.1459(7)Å b=9.9506(7)Å c=18.3720(13)Å
α=90.00° β=95.097(3)° γ=90.00°
<i>N</i>-(2-Formylphenyl)-4-methoxy-<i>N</i>-(4- methoxyphenylsulfonyl)benzenesulfonamide
C21H19NO7S2
Acta Crystallographica Section E (2011) 67, 12 o3304
a=9.0559(3)Å b=25.8904(10)Å c=9.3844(3)Å
α=90.00° β=103.423(2)° γ=90.00°
Ethyl 3-[6-(4-methoxybenzenesulfonamido)-2<i>H</i>-indazol-2-yl]propanoate monohydrate
C19H21N3O5S,H2O
Acta Crystallographica Section E (2013) 69, 2 o190-o191
a=9.0248(3)Å b=8.7602(3)Å c=13.1792(4)Å
α=90.00° β=101.062(2)° γ=90.00°